share_log

CVS Health | 8-K: Current report

CVS Health | 8-K: Current report

西维斯健康 | 8-K:重大事件
美股SEC公告 ·  12/09 07:11

Moomoo AI 已提取核心信息

CVS Health announced the results of its cash tender offer for any and all of its 4.100% Senior Notes due 2025. As of December 6, 2024, $225,979,000 principal amount was validly tendered, with an additional $5,000 tendered under guaranteed delivery procedures. The settlement date is expected to be December 11, 2024.CVS Health plans to accept all validly tendered notes for purchase. The tender offer will be funded using proceeds from the issuance of new junior subordinated notes. The company also announced a concurrent Maximum Tender Offer for other notes, with a maximum purchase price of $2 billion less the amount paid for the 2025 Notes.The tender offers are part of CVS Health's ongoing efforts to manage its debt profile. As of September 30, 2024, the company operated over 9,000 retail locations, 900+ walk-in clinics, and served approximately 90 million pharmacy benefits members, showcasing its significant presence in the healthcare sector.
CVS Health announced the results of its cash tender offer for any and all of its 4.100% Senior Notes due 2025. As of December 6, 2024, $225,979,000 principal amount was validly tendered, with an additional $5,000 tendered under guaranteed delivery procedures. The settlement date is expected to be December 11, 2024.CVS Health plans to accept all validly tendered notes for purchase. The tender offer will be funded using proceeds from the issuance of new junior subordinated notes. The company also announced a concurrent Maximum Tender Offer for other notes, with a maximum purchase price of $2 billion less the amount paid for the 2025 Notes.The tender offers are part of CVS Health's ongoing efforts to manage its debt profile. As of September 30, 2024, the company operated over 9,000 retail locations, 900+ walk-in clinics, and served approximately 90 million pharmacy benefits members, showcasing its significant presence in the healthcare sector.
西维斯健康宣布其对任何及所有到期于2025年的4.100%高级票据的现金投标结果。截至2024年12月6日,有效投标的本金金额为225,979,000美元,另有5,000美元根据担保交付程序进行投标。预计结算日期为2024年12月11日。西维斯健康计划接受所有有效投标的票据进行购买。投标将使用新发行的次级后付票据的收益进行融资。该公司还宣布了一项与之同时进行的其他票据的最大投标,最高购买价格为20亿减去为2025年票据支付的金额。这些投标是西维斯健康持续努力管理其债务结构的一部分。截至2024年9月30日,公司运营超过9,000个零售网点,900多个步入式诊所,服务约9000万药房福利会员,展示了其在医疗保健板块的重要存在。
西维斯健康宣布其对任何及所有到期于2025年的4.100%高级票据的现金投标结果。截至2024年12月6日,有效投标的本金金额为225,979,000美元,另有5,000美元根据担保交付程序进行投标。预计结算日期为2024年12月11日。西维斯健康计划接受所有有效投标的票据进行购买。投标将使用新发行的次级后付票据的收益进行融资。该公司还宣布了一项与之同时进行的其他票据的最大投标,最高购买价格为20亿减去为2025年票据支付的金额。这些投标是西维斯健康持续努力管理其债务结构的一部分。截至2024年9月30日,公司运营超过9,000个零售网点,900多个步入式诊所,服务约9000万药房福利会员,展示了其在医疗保健板块的重要存在。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息